Concord Drugs Limited (CONCORD.BO)
INR 29.95
(0.0%)
INR 29.95
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 24.87 Million INR | -15.26% |
| 2022 | 29.46 Million INR | -24.73% |
| 2021 | 39.14 Million INR | 101.65% |
| 2020 | 19.41 Million INR | -1.38% |
| 2019 | 19.68 Million INR | -2.7% |
| 2018 | 20.22 Million INR | -19.3% |
| 2017 | 25.06 Million INR | -18.28% |
| 2016 | 30.67 Million INR | -45.07% |
| 2015 | 55.84 Million INR | 48.28% |
| 2014 | 37.65 Million INR | 70.48% |
| 2013 | 22.08 Million INR | 38.29% |
| 2012 | 15.97 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 4.93 Million INR | 2889.43% |
| 2023 FY | 24.96 Million INR | -15.26% |
| 2023 Q4 | -435 Thousand INR | -118.14% |
| 2023 Q3 | 2.39 Million INR | -80.29% |
| 2023 Q2 | 12.16 Million INR | 13.09% |
| 2023 Q1 | 10.75 Million INR | 70.72% |
| 2022 Q4 | 6.3 Million INR | -40.85% |
| 2022 FY | 29.46 Million INR | -24.73% |
| 2022 Q3 | 10.65 Million INR | 61.57% |
| 2022 Q2 | 6.59 Million INR | 11.46% |
| 2022 Q1 | 5.91 Million INR | 100.41% |
| 2021 Q1 | 17.57 Million INR | 329.05% |
| 2021 Q2 | 10.99 Million INR | -37.44% |
| 2021 Q4 | 2.95 Million INR | -61.23% |
| 2021 Q3 | 7.61 Million INR | -30.78% |
| 2021 FY | 39.14 Million INR | 101.65% |
| 2020 Q4 | 4.09 Million INR | 51.34% |
| 2020 FY | 19.41 Million INR | -1.38% |
| 2020 Q3 | 2.7 Million INR | -54.72% |
| 2020 Q1 | 6.62 Million INR | 82.23% |
| 2020 Q2 | 5.97 Million INR | -9.76% |
| 2019 FY | 19.68 Million INR | -2.7% |
| 2019 Q2 | 5.3 Million INR | -13.08% |
| 2019 Q4 | 3.63 Million INR | -21.72% |
| 2019 Q3 | 4.64 Million INR | -12.39% |
| 2019 Q1 | 6.1 Million INR | -5.25% |
| 2018 Q2 | 4.38 Million INR | -9.69% |
| 2018 FY | 20.22 Million INR | -19.3% |
| 2018 Q4 | 6.43 Million INR | 41.65% |
| 2018 Q1 | 4.85 Million INR | -10.2% |
| 2018 Q3 | 4.54 Million INR | 3.58% |
| 2017 Q1 | 605 Thousand INR | 102.82% |
| 2017 FY | 25.06 Million INR | -18.28% |
| 2017 Q4 | 5.41 Million INR | -42.59% |
| 2017 Q3 | 9.42 Million INR | 1018.15% |
| 2017 Q2 | 843 Thousand INR | 39.34% |
| 2016 Q1 | 2.26 Million INR | -41.93% |
| 2016 FY | 30.67 Million INR | -45.07% |
| 2016 Q3 | 24.42 Million INR | 393.12% |
| 2016 Q4 | -21.42 Million INR | -187.72% |
| 2016 Q2 | 4.95 Million INR | 118.62% |
| 2015 Q4 | 3.9 Million INR | -85.39% |
| 2015 Q2 | 3.51 Million INR | 9.35% |
| 2015 Q1 | 3.21 Million INR | 454.21% |
| 2015 FY | 55.84 Million INR | 48.28% |
| 2015 Q3 | 26.71 Million INR | 660.97% |
| 2014 Q1 | 1.43 Million INR | 15.73% |
| 2014 FY | 37.65 Million INR | 70.48% |
| 2014 Q4 | 579.2 Thousand INR | -64.53% |
| 2014 Q3 | 1.63 Million INR | 8.87% |
| 2014 Q2 | 1.5 Million INR | 4.53% |
| 2013 Q3 | 5.79 Million INR | 10.15% |
| 2013 Q2 | 5.26 Million INR | 17.03% |
| 2013 Q4 | 1.24 Million INR | -78.61% |
| 2013 FY | 22.08 Million INR | 38.29% |
| 2013 Q1 | 4.49 Million INR | 70.75% |
| 2012 FY | 15.97 Million INR | 0.0% |
| 2012 Q4 | 2.63 Million INR | -44.14% |
| 2012 Q3 | 4.71 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -4576.946% |
| Sastasundar Ventures Limited | -229.64 Million INR | 110.83% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 165.874% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 74.793% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 59.41% |
| Sunil Healthcare Limited | -19.98 Million INR | 224.478% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | -51.336% |
| MedPlus Health Services Limited | 1.31 Billion INR | 98.115% |
| Zenith Healthcare Limited | 196 Thousand INR | -12589.796% |
| Patidar Buildcon Limited | -1.83 Million INR | 1454.684% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 61.421% |
| Roopa Industries Limited | 48.05 Million INR | 48.245% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Trident Lifeline Limited | 72.21 Million INR | 65.556% |
| Bacil Pharma Limited | -1.89 Million INR | 1412.964% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 116.658% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -176.663% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 115.538% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | -45.238% |
| PANJON LTD. | - INR | -Infinity% |
| Tyche Industries Limited | 111.22 Million INR | 77.638% |
| Trimurthi Limited | -6.14 Million INR | 504.881% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 238.818% |
| Anuh Pharma Limited | 682.19 Million INR | 96.354% |
| Crestchem Limited | 27.25 Million INR | 8.746% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 311.587% |
| Zenlabs Ethica Limited | 89.27 Million INR | 72.141% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 92.673% |
| ANG Lifesciences India Limited | 12.8 Million INR | -94.237% |
| Parmax Pharma Limited | 3.75 Million INR | -562.45% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 93.172% |
| Deccan Health Care Limited | 185.32 Million INR | 86.58% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 89.473% |
| Norris Medicines Limited | 11.15 Million INR | -122.924% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 88.468% |
| Veerhealth Care Limited | 34.19 Million INR | 27.258% |
| Makers Laboratories Limited | -34.91 Million INR | 171.246% |
| Lactose (India) Limited | 137.78 Million INR | 81.949% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 120.128% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 94.306% |
| Mercury Laboratories Limited | 62.14 Million INR | 59.979% |
| Gennex Laboratories Limited | 146.61 Million INR | 83.036% |
| PRAVEG LIMITED | 185.06 Million INR | 86.561% |
| Denis Chem Lab Limited | 142.87 Million INR | 82.592% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 95.033% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 96.282% |
| Colinz Laboratories Limited | 14.64 Million INR | -69.856% |
| Godavari Drugs Limited | -67.67 Million INR | 136.754% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 6226.108% |
| Zenotech Laboratories Limited | 242.37 Million INR | 89.738% |
| Panchsheel Organics Limited | 288.28 Million INR | 91.373% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 95.655% |
| Vivanza Biosciences Limited | 14.83 Million INR | -67.691% |
| Phaarmasia Limited | - INR | -Infinity% |
| Bharat Parenterals Limited | 733.49 Million INR | 96.609% |
| Medi-Caps Limited | -17.21 Million INR | 244.521% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 53.718% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 97.088% |
| BDH Industries Limited | 169.01 Million INR | 85.284% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 345.117% |
| Coral Laboratories Limited | 142.63 Million INR | 82.562% |
| Beryl Drugs Limited | 14.73 Million INR | -68.83% |
| Evoq Remedies Limited | 42.91 Million INR | 42.046% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 67.936% |
| Transchem Limited | -17.43 Million INR | 242.623% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -212.149% |
| Parnax Lab Limited | 166.84 Million INR | 85.093% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 27.179% |
| Kerala Ayurveda Limited | 48.04 Million INR | 48.233% |
| Cian Healthcare Limited | 53.96 Million INR | 53.914% |
| Trinity League India Limited | 1.17 Million INR | -2020.375% |
| Syschem (India) Limited | 504.91 Million INR | 95.074% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 1102.903% |
| Natural Capsules Limited | 112.4 Million INR | 77.872% |
| Auro Laboratories Limited | 95.77 Million INR | 74.031% |